Skip to main content
. 2013 Feb 22;5(5):1461–1466. doi: 10.3892/ol.2013.1209

Figure 2.

Figure 2

Kaplan-Meier curves of overall survival. (A) Overall survival of all 64 cases of resected stage I non-small cell lung cancer (NSCLC), the 5-year survival rate is 71.8%. (B) Difference between the ADAM9-high and -low groups in 64 cases of stage I NSCLC (P=0.012). (C) Difference between ADAM9-high and -low groups in 24 cases of stage IA NSCLC (P=0.049). (D) Difference between ADAM9-high and -low groups in 40 cases of stage IB NSCLC (P=0.030). ADAM9, a disintegrin and metalloproteinase-9.